A phase I study of nintedanib combined with cisplatin/gemcitabine as first-line therapy for advanced squamous non-small cell lung cancer (LUME-Lung 3)

Forster, M; Hackshaw, A; De Pas, T; Cobo, M; Garrido, P; Summers, Y; Dingemans, AMC; ... Lee, SM; + view all Forster, M; Hackshaw, A; De Pas, T; Cobo, M; Garrido, P; Summers, Y; Dingemans, AMC; Flynn, M; Schnell, D; von Wangenheim, U; Loembé, AB; Kaiser, R; Lee, SM; - view fewer (2018) A phase I study of nintedanib combined with cisplatin/gemcitabine as first-line therapy for advanced squamous non-small cell lung cancer (LUME-Lung 3). Lung Cancer , 120 pp. 27-33. 10.1016/j.lungcan.2018.03.007 . Green open access

https://ift.tt/2FAGNxN